8-K 1 body.txt NEW CEO PRESS RELEASE 1 ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.20549 -------------- FORM 8-K CURRENT REPORT -------------- PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 -------------------------------------- Date of Report (Date of earliest event reported): August 13, 2002 BIOSPHERE MEDICAL, INC. -------------------------------------------------------------- (Exact name of registrant as specified in its Charter) Delaware 0-23678 04-3216867 ------------------------- ------------ ----------------- (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.) 1050 Hingham St. Rockland, Massachusetts 02370 ---------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (781) 681-7900 ---------------------------------------------------- (Former Name or Former Address if Changed Since Last Report) ================================================================================ 2 ITEM 5. OTHER EVENTS On August 13, 2002, BioSphere Medical, Inc. issued a press release (which is attached hereto as Exhibit 99.1) announcing the election of Paul A. Looney as President and Chief Executive Officer. ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS (c) Exhibits. Exhibit 99.1 The Registrant's Press Release dated August 13, 2002. 3 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOSPHERE MEDICAL, INC. (Registrant) Date: August 13, 2002 By: /s/ Robert M. Palladino ________________________________ Vice President and Chief Financial Officer 4 EXHIBIT INDEX Exhibit Number Description ______ ______________________________ 99.1 The Registrant's Press Release dated August 13, 2002